Resmed Inc
NYSE:RMD
Relative Value
The Relative Value of one
RMD
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 240.15 USD,
Resmed Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
RMD Competitors Multiples
Resmed Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Resmed Inc
NYSE:RMD
|
35B USD | 6.5 | 23.5 | 16.6 | 18.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
191.5B USD | 4.3 | 29.3 | 16.8 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175B USD | 17.4 | 61.3 | 46.5 | 57.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
132.3B USD | 5.3 | 40.7 | 20.8 | 25.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
114.2B USD | 3.2 | 24.8 | 13.6 | 19.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.3B USD | 5.1 | 35.6 | 20.9 | 28.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
44.3B EUR | 1.9 | 21 | 11.6 | 16.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.4B USD | 8.2 | 46.1 | 25.4 | 27.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47.9B USD | 11.1 | 45.2 | 32.1 | 35.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46.5B USD | 2.1 | 26.4 | 10.3 | 17.5 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
33.1B USD | 1.6 | 15.9 | 11.4 | 13.8 |